MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study

S.H. Ou,V. Moreno Garcia,I. Gil Bazo,H. Prenen, I. Moreno, M. Johnson,E. Castañón Álvarez, M. Nagasaka, S. Adeyemi, B. Barasa,K. Bol, P. Doze, A. Engbers,A.K. Joe, V. Stalbovskaya, G. Laus, J. Call

European Journal of Cancer（2022）

Cited 0|Views19

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined